This NDC is on FDA's drug shortage list (posted Apr 2, 2020)
Product Information
MIDAZOLAM HCL 2 MG/2 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2343 per ML under NDC 00641605725. Its NADAC has been published 236 times since May 20, 2015.
FDA first approved this application on Jun 20, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641605725
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075243FDA Approved
6/20/2000
TE Code
AP
On Market Since
6/20/2000
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has been published 236 times since May 20, 2015, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2343 per ML |
|---|---|
| All-time high | $0.3151 (Feb 15, 2017) |
| All-time low | $0.1862 (Sep 18, 2024) |
| 52-week high | $0.2408 |
| 52-week low | $0.2246 |
| Median price | $0.2800 |
| Average price | $0.2634 |
| Largest weekly change | -33.5% (Sep 18, 2024) |
| Weeks tracked | 236 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 2 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 2 MG/2 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2343 per ML (NDC 00641605725), effective Aug 19, 2026.
How has the price of MIDAZOLAM HCL 2 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has declined 24.1%. It has been tracked across 236 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 2 MG/2 ML VIAL?
Since May 20, 2015, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has ranged from a low of $0.1862 (Sep 18, 2024) to a high of $0.3151 (Feb 15, 2017), with a median of $0.2800 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 2 MG/2 ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDAZOLAM HCL 2 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDAZOLAM HCL 2 MG/2 ML VIAL?
MIDAZOLAM HCL 2 MG/2 ML VIAL (NDC 00641605725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is MIDAZOLAM HCL 2 MG/2 ML VIAL in shortage?
Yes — NDC 00641605725 is currently listed in FDA's drug shortage database (posted Apr 2, 2020).